Does CYCLOPHOSPHAMIDE Cause Invasive lobular breast carcinoma? 60 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 60 reports of Invasive lobular breast carcinoma have been filed in association with CYCLOPHOSPHAMIDE (Cyclophosphamide). This represents 0.1% of all adverse event reports for CYCLOPHOSPHAMIDE.
60
Reports of Invasive lobular breast carcinoma with CYCLOPHOSPHAMIDE
0.1%
of all CYCLOPHOSPHAMIDE reports
0
Deaths
8
Hospitalizations
How Dangerous Is Invasive lobular breast carcinoma From CYCLOPHOSPHAMIDE?
Of the 60 reports, 8 (13.3%) required hospitalization, and 11 (18.3%) were considered life-threatening.
Is Invasive lobular breast carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CYCLOPHOSPHAMIDE. However, 60 reports have been filed with the FAERS database.
What Other Side Effects Does CYCLOPHOSPHAMIDE Cause?
Off label use (12,578)
Febrile neutropenia (11,318)
Drug ineffective (8,142)
Neutropenia (7,352)
Disease progression (7,100)
Pyrexia (6,126)
Product use in unapproved indication (5,750)
Thrombocytopenia (4,669)
Pneumonia (4,595)
Nausea (4,561)
What Other Drugs Cause Invasive lobular breast carcinoma?
LETROZOLE (56)
RANITIDINE (38)
TAMOXIFEN (36)
DOCETAXEL (34)
FULVESTRANT (34)
DOXORUBICIN (32)
EXEMESTANE (29)
METHOTREXATE (29)
PACLITAXEL (28)
DENOSUMAB (25)
Which CYCLOPHOSPHAMIDE Alternatives Have Lower Invasive lobular breast carcinoma Risk?
CYCLOPHOSPHAMIDE vs CYCLOPHOSPHAMIDE FOR , USP
CYCLOPHOSPHAMIDE vs CYCLOPHOSPHAMIDE\DOXORUBICIN\PREDNISONE\RITUXIMAB\VINCRISTINE
CYCLOPHOSPHAMIDE vs CYCLOPHOSPHAMIDE\DOXORUBICIN\PREDNISONE\VINCRISTINE
CYCLOPHOSPHAMIDE vs CYCLOSERINE
CYCLOPHOSPHAMIDE vs CYCLOSPORINE